Stock listing
Lang & Schwarz:A2AC9U Innoviva, Inc. Aktie
German listing (Lang & Schwarz) of Innoviva, Inc. · home listing NASDAQ:INVA
Follow Innoviva, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:INVA
$21.08 USD +0.30 (+1.4%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:INVA
- Day range
- $20.68 – $21.15 USDOct 19, 2026
- Volume
- 590,512 sharesOct 19, 2026
- Market value
- $1.52B USDAt the close on Oct 19, 2026 · price × 72.25M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INVA · Home | $21.08 USD | +0.30 (+1.4%) | 590,512 | $20.68 | $21.15 | $20.68 | $20.78 | Close on Oct 19, 2026 |
| Frankfurt:HVE | €18.70 EUR | +0.20 (+1.1%) | — | €18.40 | €18.70 | €18.40 | €18.50 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:INVA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $21.08 | +0.30 | +1.4% | $20.68 | $21.15 | $20.68 | 590,512 | |
| $20.78 | -0.08 | -0.4% | $20.97 | $20.97 | $20.56 | 550,482 | |
| $20.86 | -0.11 | -0.5% | $21.33 | $21.76 | $20.85 | 651,838 | |
| $20.97 | +0.23 | +1.1% | $20.79 | $21.18 | $20.73 | 673,500 | |
| $20.74 | -0.71 | -3.3% | $21.55 | $21.55 | $20.71 | 811,108 | |
| $21.45 | +0.24 | +1.1% | $21.27 | $21.48 | $21.12 | 521,200 | |
| $21.21 | +0.34 | +1.6% | $20.80 | $21.28 | $20.78 | 507,500 | |
| $20.87 | -0.19 | -0.9% | $21.05 | $21.05 | $20.73 | 612,300 | |
| $21.06 | +0.23 | +1.1% | $20.78 | $21.10 | $20.78 | 636,300 | |
| $20.83 | +0.19 | +0.9% | $20.78 | $20.97 | $20.62 | 679,600 | |
| $20.64 | +0.14 | +0.7% | $20.53 | $20.74 | $20.45 | 993,400 | |
| $20.50 | -0.05 | -0.2% | $20.60 | $20.76 | $20.50 | 774,700 | |
| $20.55 | -0.66 | -3.1% | $21.28 | $21.28 | $20.53 | 927,100 | |
| $21.21 | +0.10 | +0.5% | $21.11 | $21.45 | $21.06 | 1,100,100 | |
| $21.11 | -0.12 | -0.6% | $21.19 | $21.19 | $20.74 | 555,800 | |
| $21.23 | +0.49 | +2.4% | $20.74 | $21.39 | $20.59 | 854,600 | |
| $20.74 | +0.08 | +0.4% | $20.70 | $20.78 | $20.35 | 623,400 | |
| $20.66 | +0.42 | +2.1% | $20.28 | $20.79 | $20.28 | 1,368,100 | |
| $20.24 | -0.74 | -3.5% | $21.11 | $21.36 | $20.23 | 4,031,100 | |
| $20.98 | -0.06 | -0.3% | $21.17 | $21.39 | $20.96 | 931,600 | |
| $21.04 | -0.10 | -0.5% | $21.10 | $21.27 | $21.00 | 688,500 | |
| $21.14 | +0.09 | +0.4% | $20.93 | $21.18 | $20.85 | 1,437,000 | |
| $21.05 | -0.15 | -0.7% | $21.22 | $21.42 | $21.00 | 1,251,900 | |
| $21.20 | +0.36 | +1.7% | $20.86 | $21.24 | $20.86 | 715,400 | |
| $20.84 | -0.06 | -0.3% | $20.86 | $20.88 | $20.50 | 1,102,000 | |
| $20.90 | +0.24 | +1.2% | $20.93 | $21.11 | $20.69 | 885,400 | |
| $20.66 | +0.04 | +0.2% | $20.84 | $20.88 | $20.45 | 727,300 | |
| $20.62 | -0.51 | -2.4% | $21.16 | $21.24 | $20.58 | 836,400 | |
| $21.13 | -0.21 | -1.0% | $21.16 | $21.41 | $20.77 | 847,400 | |
| $21.34 | +0.01 | 0.0% | $21.06 | $21.51 | $20.87 | 782,800 | |
| $21.33 | -0.02 | -0.1% | $21.20 | $21.36 | $21.09 | 563,500 | |
| $21.35 | 0.00 | 0.0% | $21.48 | $21.48 | $21.04 | 612,300 | |
| $21.35 | +0.27 | +1.3% | $21.27 | $21.48 | $21.22 | 600,600 | |
| $21.08 | +0.31 | +1.5% | $20.97 | $21.18 | $20.94 | 798,700 | |
| $20.77 | -0.20 | -1.0% | $20.97 | $21.05 | $20.68 | 877,300 | |
| $20.97 | +0.01 | 0.0% | $20.96 | $21.07 | $20.80 | 527,000 | |
| $20.96 | -0.28 | -1.3% | $20.99 | $21.10 | $20.86 | 488,100 | |
| $21.24 | +0.07 | +0.3% | $21.15 | $21.33 | $20.84 | 693,000 | |
| $21.17 | +0.14 | +0.7% | $21.10 | $21.24 | $20.93 | 412,689 | |
| $21.03 | -0.04 | -0.2% | $21.07 | $21.10 | $20.89 | 510,303 | |
| $21.07 | +0.07 | +0.3% | $21.01 | $21.23 | $20.90 | 499,400 | |
| $21.00 | -0.48 | -2.2% | $21.34 | $21.41 | $20.87 | 796,500 | |
| $21.48 | +0.23 | +1.1% | $21.45 | $21.70 | $21.36 | 505,500 | |
| $21.25 | +0.29 | +1.4% | $21.24 | $21.46 | $21.21 | 628,800 | |
| $20.96 | -0.23 | -1.1% | $21.04 | $21.20 | $20.84 | 618,000 | |
| $21.19 | +0.44 | +2.1% | $20.72 | $21.22 | $20.68 | 448,800 | |
| $20.75 | -0.06 | -0.3% | $21.00 | $21.01 | $20.59 | 527,200 | |
| $20.81 | +0.06 | +0.3% | $20.69 | $21.12 | $20.62 | 595,900 | |
| $20.75 | +0.07 | +0.3% | $20.68 | $20.86 | $20.54 | 596,000 | |
| $20.68 | +0.17 | +0.8% | $20.42 | $20.82 | $20.39 | 877,600 | |
| $20.51 | -0.60 | -2.8% | $20.93 | $20.96 | $20.20 | 1,143,300 | |
| $21.11 | +0.60 | +2.9% | $21.13 | $22.09 | $20.74 | 1,311,000 | |
| $20.51 | -0.35 | -1.7% | $21.01 | $21.13 | $20.49 | 702,900 | |
| $20.86 | +0.09 | +0.4% | $20.64 | $20.88 | $20.50 | 564,600 | |
| $20.77 | -0.20 | -1.0% | $20.97 | $21.16 | $20.60 | 799,100 | |
| $20.97 | -0.25 | -1.2% | $21.07 | $21.08 | $20.82 | 508,000 | |
| $21.22 | -0.42 | -1.9% | $21.35 | $21.42 | $21.09 | 508,600 | |
| $21.64 | -0.17 | -0.8% | $21.76 | $21.85 | $21.40 | 536,300 | |
| $21.81 | +0.51 | +2.4% | $21.50 | $21.95 | $21.50 | 605,800 | |
| $21.30 | -0.14 | -0.7% | $21.50 | $21.79 | $21.28 | 624,300 | |
| $21.44 | +0.24 | +1.1% | $21.41 | $21.49 | $21.29 | 550,400 | |
| $21.20 | -0.23 | -1.1% | $21.36 | $21.45 | $21.05 | 942,300 | |
| $21.43 | -0.15 | -0.7% | $21.68 | $21.70 | $21.26 | 482,100 | |
| $21.58 | +0.30 | +1.4% | $21.19 | $21.73 | $21.19 | 606,600 | |
| $21.28 | -0.43 | -2.0% | $21.66 | $21.84 | $21.22 | 705,600 |
- Ticker
- Lang & Schwarz:A2AC9U
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 19, 2026
Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 30 slides
Latest news
Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026
Oct 19, 2026
Closed $21.08 (+1.4%) on Oct 19, 2026
Innoviva Specialty Therapeutics' Antimicrobial Therapies, XACDURO(R), ZEVTERA(R) and NUZOLVENCE(R) Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
Aug 12, 2026
Closed $20.81 (+0.3%) on Aug 12, 2026
Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
Aug 11, 2026
Closed $20.81 (+0.3%) on Aug 12, 2026
Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress
Aug 5, 2026
Closed $21.11 (+2.9%) on Aug 6, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 30 slides · August 2026
Investor Presentation (May 2024)
Investor deck · 28 slides · May 13, 2024
Technical Presentation (November 2023)
Technical · 7 slides · Nov 6, 2023
Investor Presentation (May 2023)
Investor deck · 22 slides · May 24, 2023
Innoviva, Inc. on 6ix
- News releases
- 16 in the last 12 months · 90 in all · newest Oct 19, 2026 · oldest 2019
- Decks
- 17 decks · latest August 2026
Where Innoviva, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INVA · Home listing | NASDAQ | United States | USD |
| gettex:HVE | gettex | Germany | EUR |
| LS Exchange:A2AC9U | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2AC9U · This page | Lang & Schwarz | Germany | EUR |
| Frankfurt:HVE | Frankfurt | Germany | EUR |
| BOATS:INVA | BOATS | United States | USD |
| Tradegate:HVE | Tradegate | Germany | EUR |
| Munich:HVE | Munich | Germany | EUR |
| BX Swiss:HVE | BX Swiss | Switzerland | CHF |
| Dusseldorf:HVE | Dusseldorf | Germany | EUR |
| Stuttgart:HVE | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Innoviva, Inc.